StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Post by Skrit37on Sep 19, 2020 7:22am

384 Views

Post# 31586541

Takeover Deal?

Hypothetically, Clarus/Echelon could broker this deal with someone they have in mind already, The takeover party requests that they need to push the float down (RS)....... reach( Nasdaq)and announce major partnership( "infrastructure in place to sell Aristotle ") once those 3 things have happened successfully, only then will the offer be made This is in the realm of possibility?

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading